Himbert Dominique, Klutman Martin, Steg Gabriel, White Kami, Gulba Dietrich C
Department of Cardiology, Hôpital Bichat-Claude Bernard, AP-HP, 46, rue Henri Huchard, 75018 Paris, France.
Int J Cardiol. 2005 Apr 8;100(1):109-17. doi: 10.1016/j.ijcard.2004.10.004.
To determine the impact of cigarette smoking on the presentation, treatment, and in-hospital outcomes of patients admitted with the full spectrum of acute coronary syndromes.
GRACE is a multinational observational registry involving 94 hospitals in 14 countries. This analysis is based on 19,325 patients aged at least 18 years admitted for acute coronary syndromes as a presumptive diagnosis with at least one of the following: electrocardiographic changes consistent with acute coronary syndromes, serial increases in serum biochemical markers of cardiac necrosis, and/or documentation of coronary artery disease. The main outcomes measured were mode of presentation, treatment and in-hospital death in the ST-segment elevation myocardial infarction, non-ST-segment elevation myocardial infarction, and unstable angina groups to assess the impact of smoking status.
Smokers were more frequently diagnosed with ST-segment elevation myocardial infarction (46.0%) than former smokers (27.4%) and non-smokers (30.2%) (P<0.001). Smokers were mostly men, were younger and more aggressively treated than former smokers and non-smokers across the three acute coronary syndrome groups. Unadjusted in-hospital mortality rates were lower in smokers compared with former smokers and non-smokers in the study population (3.3%, 4.5%, and 6.9%, respectively, P<0.001), and in the ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction groups. However, by multivariate logistic analysis, the adjusted in-hospital mortality rate was similar regardless of smoking status.
There is no survival advantage related to current or prior cigarette smoking in patients admitted with acute coronary syndromes, regardless of presentation. In this large multinational registry, the smokers' paradox does not exist.
确定吸烟对各类急性冠脉综合征患者的临床表现、治疗及住院结局的影响。
全球急性冠状动脉事件注册研究(GRACE)是一项跨国观察性注册研究,涉及14个国家的94家医院。本分析基于19325例年龄至少18岁、因急性冠脉综合征入院且被初步诊断为具有以下至少一项情况的患者:与急性冠脉综合征一致的心电图改变、心肌坏死血清生化标志物的系列升高和/或冠状动脉疾病的记录。主要测量的结局是ST段抬高型心肌梗死、非ST段抬高型心肌梗死和不稳定型心绞痛组的临床表现方式、治疗及住院死亡情况,以评估吸烟状态的影响。
吸烟者被诊断为ST段抬高型心肌梗死的比例(46.0%)高于既往吸烟者(27.4%)和非吸烟者(30.2%)(P<0.001)。吸烟者多为男性,在三个急性冠脉综合征组中,他们比既往吸烟者和非吸烟者更年轻,接受的治疗也更积极。在研究人群中,吸烟者的未调整住院死亡率低于既往吸烟者和非吸烟者(分别为3.3%、4.5%和6.9%,P<0.001),在ST段抬高型心肌梗死和非ST段抬高型心肌梗死组中也是如此。然而,通过多因素逻辑分析,无论吸烟状态如何,调整后的住院死亡率相似。
对于因急性冠脉综合征入院的患者,无论临床表现如何,目前或既往吸烟均无生存优势。在这个大型跨国注册研究中,吸烟者悖论不存在。